- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03438201
Protein Intake Associated With Physical Activity Related to Specific Outcomes (STRENGTH)
The Efficiency of Different Amount of Protein Intake Associated With a Physical Activity Protocol in Surgical Cancer Patients Admitted to the Intensive Care Unit : Randomized Controlled Trial
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Surgical cancer patients will be categorized by their nutritional risk using a specific screening toll. During the hospital stay some measurements will be done. Such as resting energy expenditure (REE) before and after surgery; physical function evaluation; strength and quality of life.
The proposed intervention is a post operative diet with a different amount of protein (diet with a standard amount of protein and a diet with high amount of protein) associated to an institutional protocol of physical activity.
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
SP
-
São Paulo, SP, Brasilien, 01246-903
- Faculty of Medicine University of Sao Paulo
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Cancer patients
- Age greater than or equal to 18 years old
- Have a tendency to be admitted to the ICU after the surgery
- Fill the eligible criteria to start enteral feeding within 72 hours
- Sign the consent form;
Exclusion Criteria:
- Mechanical ventilation such as fraction of inspired oxygen inspired oxygen fraction (FiO2) >60% or positive end expiratory pressure (PEEP) > 12cm H2O
- Bronchopleural fistula
- Karnofsky <50
- Participant cannot b enrolled in another study
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: High-protein diet
High Protein Diet (2,0 - 2,5g/Kg body weight/day) Physical Activity protocol
|
Enteral feeding that will give the patient the amount of protein between 2.0 - 2.5 Kg/body weight/Day
Andre navne:
|
Aktiv komparator: Normoproteic diet
Standard Protein Diet (1,0 - 1,2g/Kg body weight/day) Physical Activity protocol
|
Enteral feeding that will give the patient the amount of protein between 1.0 - 1.2 Kg/body weight/Day
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Physical Function
Tidsramme: 8 days after randomization
|
6 minutes walk test
|
8 days after randomization
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Physical Function
Tidsramme: 30 days after randomization
|
6-minute walk test after 30 days the date of randomization;
|
30 days after randomization
|
Quality of life
Tidsramme: 6 months after randomization
|
Measurement of quality of life using the Euro-Qol 5D-5L index.
EQ-5D-5L index includes five questions concerning mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
A summary utility index value can be computed from subject's response to these five questions.
Values range from -0.594 (worst possible health score) to 0 (death) to 1.000 (best health).
|
6 months after randomization
|
Body Composition related to prognosis
Tidsramme: 8 days after randomization
|
Phase Angle (BIA)
|
8 days after randomization
|
Postoperative complications
Tidsramme: 30 days after randomization
|
Clavien Dindo
|
30 days after randomization
|
Resting Energy Expenditure
Tidsramme: one day before surgery and one day after surgery
|
Indirect Calorimetry
|
one day before surgery and one day after surgery
|
Length of hospital stay.
Tidsramme: 30 days after randomization
|
Starts in the first day of hospitalization and ends on the day of hospital discharge
|
30 days after randomization
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Juliano P Almeida, Professor, University of Sao Paulo
- Ledende efterforsker: Ilana Roitman, University of Sao Paulo
Datoer for undersøgelser
Studer store datoer
Studiestart (Forventet)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 77623917.0.0000.0065
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Intervention
-
Biolux Research Holdings, Inc.AfsluttetOrtodontisk tandbevægelseCanada
-
University of FloridaAfsluttetFølsomhedForenede Stater
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); National Institute on Minority Health...RekrutteringHuman papillomavirus infektionForenede Stater
-
Roswell Park Cancer InstituteAfsluttetFedme | Overvægtig | Anatomisk fase I brystkræft AJCC v8 | Anatomisk fase IA brystkræft AJCC v8 | Anatomisk fase IB brystkræft AJCC v8 | Anatomisk fase II brystkræft AJCC v8 | Anatomisk fase IIA brystkræft AJCC v8 | Anatomisk fase IIB brystkræft AJCC v8 | Anatomisk fase III brystkræft AJCC v8 | Anatomisk fase... og andre forholdForenede Stater
-
Mayo ClinicAktiv, ikke rekrutterende
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityAfsluttetOndartet neoplasmaForenede Stater
-
Fred Hutchinson Cancer CenterPrevent Cancer FoundationAfsluttet
-
M.D. Anderson Cancer CenterTrukket tilbageStadie IB3 Livmoderhalskræft FIGO 2018 | Fase II Livmoderhalskræft FIGO 2018 | Fase IIA Livmoderhalskræft FIGO 2018 | Fase IIA1 Livmoderhalskræft FIGO 2018 | Fase IIA2 Livmoderhalskræft FIGO 2018 | Stadie IIB Livmoderhalskræft FIGO 2018 | Stadie III livmoderhalskræft FIGO 2018 | Fase IIIA Livmoderhalskræft... og andre forhold
-
University of South CarolinaGuangxi Zhuang Autonomous Region Center for Disease Prevention and ControlIkke rekrutterer endnuHIV/AIDS | Følelsesmæssig tilpasning | Stigma, socialForenede Stater
-
Ohio State University Comprehensive Cancer CenterRekrutteringOndartet fast neoplasma | Neoplasma i hæmatopoietisk og lymfoid systemForenede Stater